In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.

All Wales Medicines Strategy Group (AWMSG) Guidance

All Wales Multidisciplinary Reconciliation Policy
 
The All Wales Multidisciplinary Medicines Reconciliation Policy document has been developed to provide healthcare professionals with information to promote the safe and timely completion of medicines reconciliation and provides guidance on completing the process.  The guidance can be accessed here


Medicines Identified as Low Priority for Funding in NHS Wales 

The Medicines Identified as Low Priority for Funding in NHS Wales document has been developed to provide healthcare professionals with information to minimise the prescribing of medicines that offer a limited clinical benefit to patients and where more cost effective treatments may be available.  Five medicines have been identified for the purposes of this document: co-proxamol, lidocaine plasters, tadalafil once daily preparations, liothyronine and doxazosin modified release tablets.  A guidance document has been prepared by the NHS Wales Pharmacy Directors with support from the All Wales Therapeutics and Toxicology Centre (AWTTC), and has been endorsed by the All Wales Medicines Strategy Group (AWMSG) at their October 2017 meeting. The guidance can be accessed here